STOCK MARKET BSE NSE

HDFC Life net profit declines 33 per cent to Rs 302 crore in Financial Year 22 first quarter

The insurer though has witnessed a 20 per cent growth in renewal premium in April-June of 2021-22.

Published: 19th July 2021 04:23 PM  |   Last Updated: 19th July 2021 04:23 PM   |  A+A-

HDFC Life logo

HDFC Life | Wikimedia Commons

By PTI

New Delhi: HDFC Life on Monday reported a 33 per cent decline in its net profit to Rs 302 crore in the first quarter ended June this fiscal, mainly due to the adverse impact of the coronavirus pandemic.

The insurer had posted a net profit of Rs 451 crore in the same quarter previous fiscal.

The total premium during Q1 FY22, however, increased by 31 per cent to Rs 7,656 crore as against Rs 5,863 crore in the same period of FY21, HDFC Life said in a regulatory filing.

The insurer witnessed a 20 per cent growth in renewal premium in April-June of 2021-22.

"In the quarter gone by, we witnessed a steep rise in death claims with peak claims in wave two at around 3-4 times of the peak claim volumes in the first wave. We paid over 70,000 claims in Q1. The gross and net claims provided amounted to Rs 1,598 crore and Rs 956 crore, respectively. It appears that claims on individual business have peaked in June and expect them to normalise in the coming months with more people getting vaccinated and a fall in the absolute number of infections," HDFC Life said on the impact of the pandemic on the business during the quarter.

However, it said, with signs of the second wave receding, the company is seeing a gradual pick-up in economic activity across parts of the country, starting June.

While the economic restrictions in the second wave were fewer and more localised as compared to the first wave, the health impact was a lot more devastating, across our country.

"Against this backdrop, we recorded a 22 per cent growth and a market share of 17. 8 per cent in terms of individual WRP (weighted received premium) in Q1," the company noted.

HDFC Life said it has created Rs 700 crore of the excess mortality reserve.

The scrip of the company traded 2.62 per cent down at Rs 679.65 apiece on BSE.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp